Skip to main navigation

Skip to Content

Investors
Press Releases
Events & Presentations
Corporate Governance
Financial Information
- SEC Filings
- Quarterly Results
Stock Information
- Stock Quote & Chart
- Analyst Coverage
IR Resources

Events & Presentations

Upcoming Events

Jun 09 2023

Jun 09 2023

Disc Medicine Presents Initial Data from Phase 2 BEACON Trial

Click here for webcast

Add to Google Calendar

Past Events

May 02 2023

May 02 2023

H.C. Wainwright BioConnect Investor Conference

Click here for webcast

Apr 25 2023

Apr 25 2023

EPP Disease Webinar

Click here for webcast

Supporting Materials

Erythropoietic Protoporphyria (EPP) and Bitopertin Presentation 2 MB

Feb 16 2023

Feb 16 2023

SVB Securities Global Biopharma Conference

Click here for webcast

Aug 10 2022

Aug 10 2022

Gemini Therapeutics and Disc Medicine Announce Merger Agreement

Presentations

May 15, 2023

Corporate Presentation 2.8 MB

Apr 25, 2023

Erythropoietic Protoporphyria (EPP) and Bitopertin Presentation 2 MB

Jan 20, 2023

Novel Anti-TMPRSS6 Monoclonal Antibody Portfolio - Exclusive In-Licensing Agreement with Mabwell Therapeutics 899 KB

Aug 12, 2022

Investor Presentation 3.8 MB

Corporate Links

Our Vision
Our Science
Our Pipeline
Our Team
Careers

Social Media

Terms of Use
Privacy Policy

Copyright © 2023 Disc Medicine Inc.